A Clinical Approach to Existing and Emerging Therapeutics in Neuromyelitis Optica Spectrum Disorder

被引：0
|
作者：
Heather Y. F. Yong
Jodie M. Burton
机构：
[1] University of Calgary,Division of Neurology, Department of Clinical Neurosciences
[2] Cummings School of Medicine,Department of Community Health Sciences
[3] University of Calgary,Hotchkiss Brain Institute
[4] University of Calgary,undefined
来源：
Current Neurology and Neuroscience Reports | 2023年 / 23卷
关键词：
Neuromyelitis optica spectrum disorder; NMO; NMOSD; Disease-modifying therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 506
页数：17
相关论文
共 50 条
  • [41] Clinical characteristics of late-onset neuromyelitis optica spectrum disorder
    Min, Wanwan
    Zhang, Li
    Wang, Shengnan
    Xue, Mengru
    Guo, Chunjie
    Zhu, Mingqin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [42] Ethnic differences in clinical manifestation and outcome of neuromyelitis optica spectrum disorder
    Kim, S. -H.
    Mealy, M.
    Levy, M.
    Schmidt, F.
    Paul, F.
    Ringelstein, M.
    Aktas, O.
    Hartung, H. -P.
    Hyun, J. -W.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 99 - 99
  • [43] Clinical and MRI correlates of autonomic dysfunction in neuromyelitis optica spectrum disorder
    Kwon, Soonwook
    Kim, Ye Sel
    Kim, Juhyeon
    Kim, Byoung Joon
    Min, Ju-Hong
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [44] The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorder
    Chen Bo
    Qin Chuan
    Tao Ran
    Dong Yuan-Ji
    Ma Xue
    Chen Man
    Wu Long-Jun
    Bu Bi-Tao
    Tian Dai-Shi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 38
  • [45] Clinical Features, Disease Course and Outcome in Neuromyelitis Optica Spectrum Disorder
    Singh, Nishita
    Bhatia, Rohit
    Bali, Prerna
    Padma, M. V.
    Goyal, Vinay
    Garg, Ajay
    Dash, Deepa
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 116 - 116
  • [46] Clinical and mri correlates of autonomic dysfunction in neuromyelitis optica spectrum disorder
    Min, J. -H.
    Kwon, S.
    Kim, Y. S.
    Kim, J.
    Kwon, H.
    Shin, J. H.
    Kim, B. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 450 - 450
  • [47] Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives
    Huang, Tzu-Lun
    Wang, Jia-Kang
    Chang, Pei-Yao
    Hsu, Yung-Ray
    Lin, Cheng-Hung
    Lin, Kung-Hung
    Tsai, Rong-Kung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [48] Clinical course and prognosis of neuromyelitis optica spectrum disorder in a Moroccan cohort
    Bennis, A.
    El Otmani, H.
    Dany, F.
    El Moutawakil, B.
    Rafai, M. A.
    Slassi, I.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 691 - 692
  • [49] Neighborhood disadvantage, race, and clinical outcomes in neuromyelitis optica spectrum disorder
    Abbatemarco, J. R.
    Aboseif, A.
    Swetlik, C.
    Widmar, J.
    Harvey, T.
    Kunchok, A.
    O'Mahony, J.
    Miller, D. M.
    Conway, D. S.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (10) : 1239 - +
  • [50] Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Fung, Simon
    Shirley, Matt
    CNS DRUGS, 2023, 37 (04) : 363 - 370
12345